Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
Metabolic-Associated Fatty Liver Disease (MAFLD) is a major cause of liver diseases globally and its prevalence is expected to grow in the coming decades. The main cause of MAFLD development is changed in the composition of the extracellular matrix (ECM). Increased production of matrix molecules and...
Main Authors: | Adrian Kołakowski, Sylwia Dziemitko, Aleksandra Chmielecka, Hubert Żywno, Wiktor Bzdęga, Tomasz Charytoniuk, Adrian Chabowski, Karolina Konstantynowicz-Nowicka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/19/11380 |
Similar Items
-
How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
by: Wiktor Bzdęga, et al.
Published: (2023-10-01) -
MAFLD and CKD: An Updated Narrative Review
by: Alessandro Mantovani, et al.
Published: (2022-06-01) -
Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
by: Kamlesh K. Bhopale, et al.
Published: (2023-10-01) -
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study
by: Yusuke Johira, et al.
Published: (2023-06-01) -
Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
by: Yen-Po Lin, et al.
Published: (2021-07-01)